Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Hogy Medical Co ( (JP:3593) ) has shared an announcement.
Hogy Medical Co., Ltd. held a financial results briefing on January 29, 2026, to present its performance for the third quarter of the fiscal year ending March 2026. While specific figures were not disclosed in the release, the briefing underscores the company’s ongoing communication with investors about its financial condition and business outlook, signaling continued transparency and engagement with stakeholders.
The most recent analyst rating on (JP:3593) stock is a Hold with a Yen6991.00 price target. To see the full list of analyst forecasts on Hogy Medical Co stock, see the JP:3593 Stock Forecast page.
More about Hogy Medical Co
Hogy Medical Co., Ltd. is a Japanese medical company operating in the healthcare sector, led by Representative Director, President, and CEO Hideki Kawakubo. The company provides medical-related products and services, with a focus on supporting hospitals and medical institutions through its offerings.
Average Trading Volume: 179,322
Technical Sentiment Signal: Buy
Current Market Cap: Yen144.2B
See more insights into 3593 stock on TipRanks’ Stock Analysis page.